Rep. Cory Mills (R-FL) sent a letter Tuesday to the chairman of Sichuan Kelun-Biotech Biopharmaceutical, Mr. Liu Gexin, "demanding answers to serious allegations regarding their ties to the Chinese C ...
A panel discussion during the JPMorgan conference earlier this month examined where oncology drug development is headed, driven in part by advances in diagnostic testing.
The FDA issued a warning letter to ProRx, a compounding facility in Exton, Penn., after an inspection raised serious concerns regarding the safety and compliance of its drug products. The facility, ...